Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidGuangzhi Qu
    Ask Trek AI about this page

    Guangzhi Qu — Billing Profile & Reimbursement Data

    NPI 1790780716 · Jackson, MS · Hematology & Oncology Physician

    Customize your policy alerts

    Sign up for Guangzhi Qu — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Guangzhi Qu is a hematology & oncology physician provider located in Jackson, Mississippi. This profile covers 96 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationGuangzhi Qu
    Address2969 Curran Dr N
    CityJackson
    StateMS
    ZIP39216
    TaxonomyHematology & Oncology Physician
    NPI EnumeratedJune 16, 2005

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$9.1M
    Medicaid$0

    Key Findings

    This provider has reported $9.1M in lifetime Medicare revenue and no Medicaid billing on file, making Medicare effectively the sole public payer in the dataset. Analysts should treat this profile as Medicare-dominated when evaluating public-payer exposure, reimbursement risk, and utilization patterns.

    Revenue is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 54.0% of this provider's total Medicare revenue. Those top codes are J9271 ($2.4M, 27.4%), J1568 ($1.2M, 14.2%), and J9144 ($1.1M, 12.4%), indicating a small set of therapeutics drives the majority of Medicare payments.

    The code mix is consistent with an infusion-centered hematology/oncology practice with high use of biologics and monoclonal antibodies. Heavy billing for agents such as J9271, J9144, J9299 and J9047 alongside supportive medications like J2506 and J0897 suggests outpatient chemotherapy and biologic therapy administration are the core services delivered.

    Several top drugs place this provider well above national peers: J9271 ranks #12 of 1841 providers (99th percentile; extreme outlier) and J1568 ranks #3 of 381 providers (99th percentile; extreme outlier), while J9144 ranks #18 of 615 providers (97th percentile; notably above typical national volume). Those high ranks signal national-scale dispensing or infusion volumes for pembrolizumab, IVIG (octagam), and daratumumab relative to other clinicians.

    Multiple additional codes show extreme outlier status across different therapeutic classes, not just a single medication. Examples include J1449 at #1 of 161 providers (100th percentile; extreme outlier), J2506 at #2 of 586 providers (100th percentile; extreme outlier), and J9041 at #2 of 357 providers (100th percentile; extreme outlier), which points to unusually high volumes across a range of infused agents.

    Evaluation and management plus supportive services are also prominent: 99214 generated $181.3K (2.1% of Medicare revenue) and ranks #1029 of 479517 providers (100th percentile; extreme outlier), with 99215 contributing $54.1K (0.6%). Laboratory and infusion administration CPTs such as 80053, 85025, 83521, 96365, and 96367 appear in the top 25, indicating frequent outpatient visits, routine monitoring, and repeated infusion sessions that support the drug treatment mix.

    The pattern of specific agents and tests suggests a substantial hematologic-malignancy focus, especially multiple myeloma and plasma-cell disorders. High revenue and ranks for daratumumab (J9144), carfilzomib (J9047), bortezomib (J9041), pegfilgrastim (J2506), and serum free light chain testing (83521) support this clinical emphasis, while pembrolizumab (J9271) and nivolumab (J9299) indicate concurrent solid-tumor immunotherapy activity.

    The provider's NPI was enumerated on 2005-06-16 (~21 years ago), indicating long-standing enrollment; combined with $9.1M total Medicare revenue and multiple high-percentile code ranks, this profile is consistent with an established infusion and oncology practice that has sustained high referral and treatment volumes over time.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    96 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J9271Injection, pembrolizumab, 1 mg55,800$40$2.4M
    J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg37,720$30$1.2M
    J9144Injection, daratumumab, 10 mg and hyaluronidase‑fihj29,340$40$1.1M
    J9299Injection, nivolumab, 1 mg40,180$20$924.1K
    J9047Injection, carfilzomib, 1 mg18,600$40$669.6K
    J0897Injection, denosumab, 1 mg26,460$20$476.3K
    J1449Injection, eflapegrastim-xnst, 0.1 mg14,520$30$363K
    J9264Injection, paclitaxel protein-bound particles, 1 mg23,600$10$236K
    J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg3,060$80$232.6K
    99214The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…2,130$90$181.3K

    Showing 1–10 of 96

    • More pages

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 96 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    96 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J927121016,700$40$1M
    J904711018,600$40$668.8K
    J914411013,050$40$631.7K
    J929911021,120$20$569.7K
    J15681107,420$30$393.8K
    J93126104,130$60$258.9K
    J93113107,080$30$195.5K
    J14491104,160$30$149.3K
    J926411014,550$10$145.7K
    J089721103,030$20$95.7K

    Showing 1–10 of 96

    • More pages

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Guangzhi Qu, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Tammy YoungMSMedical Oncology Physician$5.1M$0
    Justin BakerMSHematology & Oncology Physician$4.1M$0
    Nicole ClevelandMSMedical Oncology Physician$2.8M$0
    Thomas WilliamsonNCHematology & Oncology Physician$2.4M$0
    Manubhai PatelMSMedical Oncology Physician$1.9M$0
    Elizabeth HerringtonMSMedical Oncology Physician$1.9M$0
    Natale SheehanMSMedical Oncology Physician$1.4M$0
    Bobby GrahamMSHospice and Palliative Medicine (Internal Medicine) Physician$143.8K$0
    Donald TisdaleMSFamily Nurse Practitioner$113.4K$0
    Meaghan JohnsonMSFamily Nurse Practitioner$98.5K$0

    Nearby Providers

    Other providers in the same ZIP code as Guangzhi Qu, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    State Of Mississippi - University Of Mississippi Medical CenterMSGeneral Acute Care Hospital$0$507.2M
    Central Ms. Planning & Dev. District, Inc.MSCase Management Agency$0$47.2M
    St Dominic-jackson Memorial HospitalMSGeneral Acute Care Hospital$0$37.1M
    Afnb Home Care LLCMSIn Home Supportive Care Agency$0$25.6M
    Ms Children's Home SocietyMSCommunity/Behavioral Health Agency$0$19.4M
    Mississippi State Department Of HealthMSCommunity/Behavioral Health Agency$0$14.9M
    Ms State Department Of HealthMSCommunity/Behavioral Health Agency$0$14.5M
    Mississippi Asthma & Allergy Clinic PAMSAllergy & Immunology Physician$0$8.2M
    Mississippi Methodist Hospital & Rehabilitation Center, Inc.MSGeneral Acute Care Hospital$0$5.7M
    Jerrick RoseMSPediatric Dentistry$0$4.6M

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. Mississippi Distribution
    Guangzhi Qu — 20 of 25 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Mississippi